Drug Treatment of Herpes Simplex Infection

被引:1
作者
Lee, Eun-So [1 ]
机构
[1] Ajou Univ, Sch Med, Dept Dermatol, Suwon 441749, South Korea
来源
JOURNAL OF THE KOREAN MEDICAL ASSOCIATION | 2008年 / 51卷 / 10期
关键词
Herpes simplex virus; Antiviral agents; Therapy;
D O I
10.5124/jkma.2008.51.10.942
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Herpes simplex virus (HSV) is one of Herpesviridae family viruses which belong to DNA viruses. HSV-associated diseases are among the most widespread infections, affecting nearly 60% to 95% of human adults. Labial herpes typically results from infection with HSV type 1 (HSV-1), whereas most genital herpes is caused by HSV type 2 (HSV-2). They are incurable and persist during the lifetime of the host, often in latent form. Antiviral agents do not cure HSV infections, but rather modify the clinical course of the disease. Topical, oral, or intravenous antiviral agents may be used in the management of HSV infections. Acyclovir, valacyclovir hydrochloride, and famciclovir are the 3 antiviral drugs commonly used to treat symptomatic HSV infections. However, it is very difficult to choose an appropriate drug and dosing regimen.
引用
收藏
页码:942 / 948
页数:7
相关论文
共 5 条
[1]  
Dooley Samuel W., 2008, Morbidity and Mortality Weekly Report, V57, P1
[2]   The treatment of herpes simplex infections - An evidence-based review [J].
Cernik, Christina ;
Gallina, Kelly ;
Brodell, Robert T. .
ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (11) :1137-1144
[3]   Human herpes simplex virus infections: Epidemiology, pathogenesis, symptomatology, diagnosis, and management [J].
Fatahzadeh, Mahnaz ;
Schwartz, Robert A. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 57 (05) :737-763
[4]  
*KDA TXB ED BOARD, 2008, DERM, P386
[5]  
MARQUES AR, 2007, FITZPATRICKS DERMATO, P1873